The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 79, Issue 2, Pages 182-194
Publisher
Wiley
Online
2014-04-15
DOI
10.1111/bcp.12403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Age With Polypharmacy and Risk of Drug Interactions With Antiretroviral Medications in HIV-Positive Patients
- (2014) Alice Tseng et al. ANNALS OF PHARMACOTHERAPY
- Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
- (2014) Jean B. Nachega et al. CLINICAL INFECTIOUS DISEASES
- Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes
- (2014) Jackson K. Mukonzo et al. PLoS One
- Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
- (2013) Matteo Vassallo et al. AIDS
- Pharmacokinetics and Pharmacodynamics in HIV Prevention; Current Status and Future Directions: A Summary of the DAIDS and BMGF Sponsored Think Tank on Pharmacokinetics (PK)/Pharmacodynamics (PD) in HIV Prevention
- (2013) Joseph Romano et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned
- (2013) David R. Friend et al. ANTIVIRAL RESEARCH
- Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350)
- (2013) Lianhong Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control
- (2013) M. J. Mugavero et al. CLINICAL INFECTIOUS DISEASES
- Nanomedicines for Treatment of Viral Diseases
- (2013) Rujuta Mehendale et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection
- (2013) Emma D. Deeks DRUGS
- High Frequency of Hypothalamic-Pituitary-Adrenal Axis Dysfunction After Local Corticosteroid Injection in HIV-Infected Patients on Protease Inhibitor Therapy
- (2013) Emily P. Hyle et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The search for an HIV cure: tackling latent infection
- (2013) Stephen J Kent et al. LANCET INFECTIOUS DISEASES
- Finding the right chemistry
- (2013) Killugudi Jayaraman NATURE MEDICINE
- Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples
- (2013) Rochelle P. Walensky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological and Virological Benefits Resulted from Short-Course Treatment during Primary HIV Infection: A Meta-Analysis
- (2013) Jingjing Chen et al. PLoS One
- Long-acting injectable antiretrovirals for HIV treatment and prevention
- (2013) William R. Spreen et al. Current Opinion in HIV and AIDS
- Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
- (2013) Steven A. Yukl et al. PLoS Pathogens
- Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial
- (2012) David C Sokal et al. ANTIVIRAL THERAPY
- Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis
- (2012) Connie Celum et al. ANTIVIRAL THERAPY
- Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
- (2012) et al. CLINICAL INFECTIOUS DISEASES
- Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement
- (2012) Keith W Crawford et al. LANCET INFECTIOUS DISEASES
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
- (2012) Michael C. Thigpen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug hypersensitivity: Pharmacogenetics and clinical syndromes
- (2011) Elizabeth J. Phillips et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ageing with HIV: medication use and risk for potential drug-drug interactions
- (2011) C. Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Therapeutic Drug Monitoring in the Management of Patients With Human Immunodeficiency Virus Infection
- (2011) Erina Pretorius et al. THERAPEUTIC DRUG MONITORING
- Clinical Management of HIV Drug Resistance
- (2011) Karoll J. Cortez et al. Viruses-Basel
- Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs
- (2011) Alice Tseng et al. Current Infectious Disease Reports
- Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
- (2010) Esteban Martinez et al. AIDS
- Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
- (2010) Rubin Lubomirov et al. JOURNAL OF INFECTIOUS DISEASES
- Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
- (2010) Joseph J Eron et al. LANCET
- Interaction of Ginkgo biloba with efavirenz
- (2009) Dirk-Jan Wiegman et al. AIDS
- Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
- (2009) Annemarie M.J. Wensing et al. ANTIVIRAL RESEARCH
- Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
- (2009) A A Mathias et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- No Evidence for Decay of the Latent Reservoir in HIV‐1–Infected Patients Receiving Intensive Enfuvirtide‐Containing Antiretroviral Therapy
- (2009) Rajesh T. Gandhi et al. JOURNAL OF INFECTIOUS DISEASES
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protease Inhibitor Resistance Update: Where Are We Now?
- (2008) Rose Kim et al. AIDS PATIENT CARE AND STDS
- Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
- (2008) MM Foisy et al. HIV MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started